HERE FOR 20 YEARS FOR PEOPLE WITH AN INTEREST IN MULTIPLE SCLEROSIS Skip to content

Patients pay the price when pharma companies abuse the patent system

377 Views 0 Replies

0 Members and 1 Guest are viewing this topic.

#1

This is an interview but the transcript appears  as well.  The abbreviation IP is used for intellectual property.

From MedPage Today (November 25, 2022)--"Pharma Companies Abuse the Patent System, and Patients Pay the Price":




Priti Krishtel, JD, on how the U.S. patent system has
bit.ly
MS Speaks--online for 20 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week)  12/16/20 - 3/16/24.